NordIMM in short

Nordic Network on Immunotechnology

NordIMM was a parallel activity to the Swedish R&D Program on Immunotechnology. Both activities addressed the rapidly emerging technology platform of Immunotechnology when it was at its most important phase in establishing IPR protection.

The NordIMM program established 1994 one of the very first IT based professional communities via internet. It allowed for Immunotechnology professionals within Industry and Academy to discuss issues in private or via discussion groups on a so called bulletin board server.

Organization and Finance

Programme Coordination:

SBF - Biotechnology Research Foundation (Gunnar Hörnsten)

Steering Committee:

Per Vretblad, Pharmacia Biotech AB, Sweden

Lillian Reesen, Balslev & Reesen, Denmark

Margareta Bervenmark, NUTEK Swedish National Board for Industrial and Technical Development

Jan Brundell, Sangtec Medical AB

Guno Haskå, SBF - Biotechnology Research Foundation

Hanna Leena Livio, TEKES The Finnish Funding Agency for Technology and Innovation

Kjell Torgeir Stokke, PRONOVA A/S

Erling Sundrehagen, The Research Council of Norway

Hans Söderlund, VTT

Finance: Total 3,3 MSEK* (Shared cost Industry and Nordic Industry Fund)

Duration: 1994-1998

Public meetings

Advanced Nordic Immunotechnology Course, Lund, 950320-24

Selected Immunotechnological Applications from Nordic Research, Kirkonummi, 960603-04

Antibody Engineering and DNA Vaccination, Copenhagen 970609-10

Analytical Tools in Biotechnology, Stockholm 980203-04

Members

AgriSera

Amersham Pharmacia Biotech

Astra Arcus

Astra Draco

Aquateam

Biacore

Bioinvent Therapeutics

Biopool

Euro-Diagnostica

Labora

Leo Pharmaceutical

MediCult

Locus Genex

Pharmacia & Upjohn

Pharmacia & Upjohn Diagnostics

Sangtec Medical

SIK
VTT

Wallac

 

*exchange rates as of 2009-09-03